President and Chief Executive Officer
After more than 30 years in the healthcare field, Bob Moussa has a long and successful record in the medical device industry. He has held a number of senior positions at both Sherwood Medical Industries and Mallinckrodt Medical. Moussa has extensive experience launching new products in the diagnostic, nuclear medicine and medical device markets.
Based upon existing clinical results, Moussa believes that Dilon will become the standard of care as an adjunct diagnostic tool in the diagnosis of early stage breast cancer. He feels this advanced technology is a major weapon in the battle against cancer and plans to make Dilon the standard of care in the diagnostic field.
Moussa received his baccalaureate from the Collège du Sacre-Coeur, and a Higher National Diploma from the University of London in England. He has also completed executive seminars at the University of California at Berkeley, the Aspen Institute, the Wharton Executive School and the Center for Creative Leadership.